| Serial Number | 79364555 |
| Word Mark | LYSOSCORE |
| Filing Date | Thursday, January 19, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 13, 2024 |
| Registration Number | 7470189 |
| Registration Date | Tuesday, August 13, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 28, 2024 |
| Goods and Services | Medical services, medical diagnostic testing services; medical and pharmaceutical consultancy; medical analysis services relating to the diagnosis and treatment of persons; laboratory analysis services relating to the diagnosis and treatment of persons in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases; medical examinations; medical screening; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases; medical analysis services relating to the treatment of patients for diagnosising and treating illnesses |
| Goods and Services | Scientific and technological research in the field of medicine, biotechnology, biology, biomedicine, pharmaceuticals, genetics, molecular sciences, therapeutics, chemistry and biochemistry; Pharmaceutical products development; research and development of new products for others; pharmaceutical drug development services; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; database services, namely, electronic storage of data in computer databases; design, engineering, research, development and testing services in the field of pharmaceuticals, biotechnology, biology, biomedicine, genetics, molecular sciences, therapeutics, chemistry and biochemistry for medical, scientific, and technological applications; preparation of scientific analysis and evaluations namely, testing of pharmaceuticals and pharmaceutical product evaluation; consultancy relating to research and development in the field of therapeutics; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; development of pharmaceutical preparations and medicines; medical laboratory services |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 10, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 10, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Samsara Therapeutics |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | DE |
| Party Name | Samsara Therapeutics |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | DE |
| Party Name | Samsara Therapeutics |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | DE |
| Event Date | Event Description |
| Thursday, March 9, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, March 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 14, 2023 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, October 17, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, October 25, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, October 26, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, October 30, 2023 | REFUSAL PROCESSED BY MPU |
| Monday, October 30, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, November 21, 2023 | REFUSAL PROCESSED BY IB |
| Monday, March 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 8, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, April 18, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, April 18, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, April 18, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, April 18, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, April 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 28, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, August 7, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 7, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, May 28, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 13, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 13, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, November 13, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, February 4, 2025 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, February 22, 2025 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, February 3, 2025 | FINAL DISPOSITION PROCESSED |
| Saturday, August 24, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |